Other

Sales of and distributions from equity method investments

Pfizer Sales of and distributions from equity method investments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.31B to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026

How to read this metric

Higher proceeds suggest successful asset rotation or strategic exit from partnerships, providing liquidity for other investments.

Detailed definition

Cash inflows resulting from the divestiture or liquidation of interests in entities accounted for under the equity metho...

Peer comparison

Standard for midstream companies that frequently utilize joint ventures for large-scale infrastructure projects.

Metric ID: other_proceeds_from_sale_of_equity_method_investments

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.49B$3.55B$6.31B$0.00
QoQ Change+1.7%+77.8%-100.0%
YoY Change+80.8%-100.0%
Range$0.00$6.31B
Avg YoY Growth-9.6%
Median YoY Growth-9.6%

Frequently Asked Questions

What is Pfizer's sales of and distributions from equity method investments?
Pfizer (PFE) reported sales of and distributions from equity method investments of $0.00 in Q1 2026.
How has Pfizer's sales of and distributions from equity method investments changed year-over-year?
Pfizer's sales of and distributions from equity method investments decreased by 100.0% year-over-year, from $6.31B to $0.00.
What does sales of and distributions from equity method investments mean?
Cash received from selling stakes in companies where the firm holds significant influence.